US equities
|
MU
$1,066.63
▼-1.96%
NVDA
$234.47
▼-1.26%
SNDK
$1,637.45
▼-3.25%
PLTR
$198.36
▲+2.18%
AMD
$630.65
▼-2.35%
INTC
$109.01
▼-3.63%
SPCX
$163.09
▼-2.69%
META
$718.14
▼-0.44%
MU
$1,066.63
▼-1.96%
NVDA
$234.47
▼-1.26%
SNDK
$1,637.45
▼-3.25%
PLTR
$198.36
▲+2.18%
AMD
$630.65
▼-2.35%
INTC
$109.01
▼-3.63%
SPCX
$163.09
▼-2.69%
META
$718.14
▼-0.44%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Amphastar Pharmaceuticals, Inc. - Common Stock
(NQ:
AMPH
)
25.77
+0.23 (+0.90%)
Delayed Quote
Updated: 12:46 PM EDT, Oct 8, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Amphastar Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Amphastar Pharmaceuticals: Q3 Earnings Insights
↗
November 08, 2021
Amphastar Pharmaceuticals (NASDAQ:AMPH) reported its Q3 earnings results on Monday, November 8, 2021 at 04:00 PM. Here's what investors need to know about the announcement....
Via
Benzinga
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2021
November 08, 2021
Reports Net Revenues of $112.2 Million for the Three Months Ended September 30, 2021 RANCHO CUCAMONGA, CA / ACCESSWIRE / November 8, 2021 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or...
From
Amphastar Pharmaceuticals, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8th, 2021
October 28, 2021
RANCHO CUCAMONGA, CA / ACCESSWIRE / October 28, 2021 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its third quarter of 2021 ended September 30,...
From
Amphastar Pharmaceuticals, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Amphastar Pharmaceuticals to Present at the Wells Fargo 2021 Virtual Healthcare Conference
September 02, 2021
RANCHO CUCAMONGA, CA / ACCESSWIRE / September 2, 2021 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, Executive V.P. and CFO, Dan Dischner, V.P of Corporate...
From
Amphastar Pharmaceuticals, Inc.
Via
AccessWire
Topics
Regulatory Compliance
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
↗
August 08, 2021
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...
Via
Benzinga
Amphastar Pharmaceuticals, inc (AMPH) Q2 2021 Earnings Call Transcript
↗
August 09, 2021
AMPH earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2021
August 09, 2021
Reports Net Revenues of $101.7 Million for the Three Months Ended June 30, 2021 RANCHO CUCAMONGA, CA / ACCESSWIRE / August 9, 2021 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the...
From
Amphastar Pharmaceuticals, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 9th, 2021
July 29, 2021
RANCHO CUCAMONGA, CA / ACCESSWIRE / July 29, 2021 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its second quarter of 2021 ended June 30, 2021,...
From
Amphastar Pharmaceuticals, Inc.
Via
AccessWire
Topics
Regulatory Compliance
18 Key Biopharma Catalysts To Keep An Eye On In Q3
↗
July 10, 2021
Biopharma stocks underperformed in the first half of 2021, and several of these stocks could be in for a rebound in the coming months. Ne...
Via
Benzinga
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
↗
August 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (...
Via
Benzinga
Amphastar Pharmaceuticals Inc (AMPH) Q1 2021 Earnings Call Transcript
↗
May 07, 2021
AMPH earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Recap: Amphastar Pharmaceuticals Q1 Earnings
↗
May 06, 2021
Shares of Amphastar Pharmaceuticals (NASDAQ:AMPH) rose in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 58.82% over the...
Via
Benzinga
A Peek Into The Markets: US Stock Futures Gain Ahead Of Manufacturing Data
↗
May 03, 2021
Pre-open movers U.S. stock futures traded higher in early pre-market trade after the Dow Jones dipped 185 points in the previous session. However, Wall Street recorded gains for...
Via
Benzinga
Topics
Stocks
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
